Aging Restricts Maturation Of Cxcl13+ T Follicular Helper Cells In Human Immunity
As we age, our immune system doesn’t always respond as robustly as it once did, especially when it comes to fighting off infections or responding to vaccines. A key part of this decline involves specialized immune cells known as T follicular helper (Tfh) cells. These cells act like crucial guides for another type of immune cell, B cells, helping them produce powerful, long-lasting antibodies that protect us from disease. These important interactions typically happen in special “training grounds” within our lymph nodes called germinal centers.
Recent research has shed light on why these antibody responses weaken with age. It turns out that in older individuals, Tfh cells struggle to complete their full development. Instead of maturing into their most effective forms, they get stuck in an earlier, less functional state. This incomplete maturation means B cells don’t receive the optimal “help” they need, leading to weaker and less durable antibody production. Scientists discovered that specific genetic regulators, like BACH2 and SOX4, are less active in older Tfh cells, contributing to this developmental arrest. Understanding this age-related defect in Tfh cell maturation is a significant step towards developing new strategies to boost immunity and improve vaccine effectiveness in older adults, ultimately helping them stay healthier for longer.
Source: link to paper